...
机译:金融竞争利益与神经氨酰胺酶抑制剂的非系统评论中的有利结论和更高的作者生产力相关联
Centre for Health Informatics Australian Institute of Health Innovation Macquarie University;
Centre for Health Informatics Australian Institute of Health Innovation Macquarie University;
Department of Pediatrics Harvard Medical School Boston MA 02115 USA;
Centre for Health Informatics Australian Institute of Health Innovation Macquarie University;
Department of Pediatrics Harvard Medical School Boston MA 02115 USA;
Centre for Health Informatics Australian Institute of Health Innovation Macquarie University;
Department of Pediatrics Harvard Medical School Boston MA 02115 USA;
机译:金融竞争利益与神经氨酰胺酶抑制剂的非系统评论中的有利结论和更高的作者生产力相关联
机译:仅引用文献就足以预测神经氨酸酶抑制剂的评价中的有利结论。
机译:财务利益冲突和流感神经氨酸酶抑制剂的结论:系统评价的分析
机译:进行适当的外部质量保证审核对外部审核员对组织的财务报表进行审核的范围的调查(有利审核)。
机译:利益冲突与作者结论之间的关联:BMJ发表的随机临床试验的流行病学研究
机译:CS-8958,新型神经氨酸酶抑制剂R-125489的前药,在小鼠呼吸道中表现出良好的长期保留特性